X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10216) 10216
Publication (480) 480
Newsletter (386) 386
Book Chapter (44) 44
Book Review (37) 37
Magazine Article (15) 15
Dissertation (12) 12
Conference Proceeding (10) 10
Newspaper Article (6) 6
Data Set (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6251) 6251
daunorubicin (3315) 3315
male (3067) 3067
female (2936) 2936
animals (2590) 2590
daunorubicin - administration & dosage (2358) 2358
adult (2037) 2037
daunorubicin - pharmacology (1977) 1977
oncology (1974) 1974
middle aged (1898) 1898
daunorubicin - therapeutic use (1743) 1743
antineoplastic combined chemotherapy protocols - therapeutic use (1732) 1732
cytarabine - administration & dosage (1511) 1511
index medicus (1472) 1472
adolescent (1447) 1447
leukemia, myeloid, acute - drug therapy (1383) 1383
hematology (1373) 1373
aged (1304) 1304
mice (1246) 1246
child (1089) 1089
chemotherapy (1042) 1042
daunorubicin - analogs & derivatives (1038) 1038
cancer (1002) 1002
doxorubicin (976) 976
pharmacology & pharmacy (929) 929
remission induction (922) 922
daunorubicin - metabolism (915) 915
anthracyclines (875) 875
biochemistry & molecular biology (798) 798
daunorubicin - adverse effects (782) 782
child, preschool (740) 740
cytarabine - therapeutic use (724) 724
rats (698) 698
time factors (686) 686
drug resistance (677) 677
leukemia (668) 668
vincristine - administration & dosage (663) 663
acute disease (650) 650
doxorubicin - pharmacology (644) 644
p-glycoprotein (637) 637
antibiotics, antineoplastic - pharmacology (633) 633
dose-response relationship, drug (631) 631
treatment outcome (620) 620
tumor cells, cultured (619) 619
prognosis (612) 612
antineoplastic agents - pharmacology (609) 609
research (560) 560
adriamycin (558) 558
kinetics (548) 548
apoptosis (544) 544
antineoplastic combined chemotherapy protocols - adverse effects (500) 500
vincristine - therapeutic use (499) 499
leukemia - drug therapy (487) 487
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (486) 486
daunorubicin - pharmacokinetics (477) 477
drug therapy, combination (477) 477
acute myelogenous leukemia (476) 476
acute myeloid-leukemia (461) 461
cell survival - drug effects (454) 454
infant (454) 454
expression (452) 452
antineoplastic agents - therapeutic use (449) 449
therapy (446) 446
multidrug resistance (445) 445
cell line, tumor (442) 442
daunorubicin - toxicity (437) 437
antineoplastic agents (430) 430
acute myeloid leukemia (425) 425
leukemia, myeloid - drug therapy (414) 414
prednisone - administration & dosage (412) 412
dna (399) 399
drug resistance, neoplasm (397) 397
daunorubicin - chemistry (392) 392
cell line (391) 391
cytarabine (388) 388
drug resistance, multiple (382) 382
multidrug-resistance (377) 377
apoptosis - drug effects (372) 372
cyclophosphamide - administration & dosage (369) 369
leukemia, lymphoid - drug therapy (367) 367
cells (365) 365
idarubicin (365) 365
leukemia, myeloid, acute - mortality (365) 365
analysis (363) 363
methotrexate - administration & dosage (362) 362
antineoplastic combined chemotherapy protocols - administration & dosage (358) 358
disease-free survival (351) 351
antibiotics, antineoplastic - administration & dosage (348) 348
antimitotic agents (348) 348
cells, cultured (348) 348
daunomycin (347) 347
drug administration schedule (342) 342
prednisone - therapeutic use (340) 340
doxorubicin - administration & dosage (337) 337
asparaginase - administration & dosage (336) 336
doxorubicin - therapeutic use (336) 336
thioguanine - administration & dosage (334) 334
flow cytometry (333) 333
etoposide - administration & dosage (330) 330
antibiotics, antineoplastic - therapeutic use (324) 324
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9291) 9291
Russian (320) 320
Japanese (235) 235
German (199) 199
French (152) 152
Chinese (136) 136
Italian (130) 130
Spanish (67) 67
Polish (62) 62
Czech (18) 18
Danish (9) 9
Hungarian (5) 5
Korean (5) 5
Dutch (4) 4
Swedish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Romanian (3) 3
Serbian (3) 3
Croatian (2) 2
Portuguese (2) 2
Slovak (2) 2
Bosnian (1) 1
Catalan (1) 1
Norwegian (1) 1
Persian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 2010, Volume 141, Issue 2, pp. 183 - 192
Chemotherapy for brain glioma has been of limited value due to the inability of transport of drug across the blood-brain barrier (BBB) and poor penetration of... 
Brain glioma-bearing rats | Dual-targeting | Blood-brain barrier | Survival | Daunorubicin liposomes modified with MAN and TF | CELLS | TRANSFERRIN-RECEPTOR | SOLID TUMORS | DRUG-DELIVERY | BARRIER | CANCER | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | IN-VITRO | TRANSPORT | GROWTH | PHARMACOLOGY & PHARMACY | Capillary Permeability | Antibiotics, Antineoplastic - pharmacology | Aniline Compounds - metabolism | Brain Neoplasms - pathology | Cell Membrane Permeability | Daunorubicin - pharmacology | Male | Mannosides - chemistry | Brain Neoplasms - metabolism | Drug Carriers | Glioma - metabolism | Flow Cytometry | Antibiotics, Antineoplastic - chemistry | Biological Transport | Time Factors | Glioma - pathology | Daunorubicin - metabolism | Spheroids, Cellular | Daunorubicin - administration & dosage | Rats | Brain Neoplasms - drug therapy | Rats, Sprague-Dawley | Chemistry, Pharmaceutical | Daunorubicin - chemistry | Blood-Brain Barrier - metabolism | Antibiotics, Antineoplastic - administration & dosage | Microscopy, Confocal | Animals | Transferrin - chemistry | Cell Line, Tumor | Cell Proliferation - drug effects | Mannosides - metabolism | Mice | Aniline Compounds - chemistry | Liposomes | Antibiotics, Antineoplastic - metabolism | Transferrin - metabolism | Glioma - drug therapy | Chemotherapy | Daunorubicin | Biomimetics | Gliomas | Analysis | Brain tumors | Health aspects | Cancer
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 21, pp. 3239 - 3246
Journal Article
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 05/2019, Volume 128, pp. 825 - 838
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 02/2013, Volume 50, Issue 2, pp. 119 - 130
This paper reviews the development of therapy for acute myelogenous leukemia that in 1973 led to the regimen of 7 days of continuous intravenous... 
Anthracycline antibiotics | Acute myelogenous leukemia | Cytosine arabinoside | Chemotherapy | Daunorubicin | Antimetabolites | ACUTE GRANULOCYTIC-LEUKEMIA | CYTOSINE-ARABINOSIDE | TREATMENT SCHEDULES | DAUNOMYCIN | LA DAUNOMICINA | ACUTE MYELOID-LEUKEMIA | 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE | THERAPY | COMBINATION CHEMOTHERAPY | RUBIDOMYCIN | HEMATOLOGY | Cancer Care Facilities - history | Cyclophosphamide - administration & dosage | History, 21st Century | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Cyclophosphamide - isolation & purification | Cyclophosphamide - adverse effects | Child | Daunorubicin - administration & dosage | Hematology - history | History, 20th Century | Mercaptopurine - administration & dosage | Rats | Forecasting | Remission Induction | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Daunorubicin - history | Cyclophosphamide - history | Cyclophosphamide - pharmacology | Adolescent | Antineoplastic Combined Chemotherapy Protocols - history | Daunorubicin - isolation & purification | Mercaptopurine - pharmacology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cytarabine - isolation & purification | Cytarabine - pharmacology | National Institutes of Health (U.S.) - history | United States | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Daunorubicin - pharmacology | Cytarabine - adverse effects | Medical Oncology - history | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Case Management - history | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Mercaptopurine - isolation & purification | France | Mercaptopurine - history | Mercaptopurine - adverse effects | Clinical Trials as Topic | Haplorhini | Animals | Cytarabine - history | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Dogs | Aged | Drug Screening Assays, Antitumor
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 12/2012, Volume 68, Issue 12, pp. 1577 - 1586
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1249 - 1259
Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice... 
CYTOSINE-ARABINOSIDE | MEDICINE, GENERAL & INTERNAL | ONCOLOGY-GROUP | INDUCTION CHEMOTHERAPY | ACUTE NONLYMPHOCYTIC LEUKEMIA | ACUTE MYELOGENOUS LEUKEMIA | ACUTE MYELOCYTIC-LEUKEMIA | GROUP-B | DAUNORUBICIN | REMISSION INDUCTION | UNTREATED ADULT PATIENTS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Myelomonocytic, Acute - drug therapy | Stem Cell Transplantation | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myelomonocytic, Acute - therapy | Adult | Female | Remission Induction - methods | Daunorubicin - administration & dosage | Leukemia, Myelomonocytic, Acute - genetics | Histone-Lysine N-Methyltransferase | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Combined Modality Therapy | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Myeloid-Lymphoid Leukemia Protein - genetics | Adolescent | Infusions, Intravenous | Mutation | Leukemia, Myelomonocytic, Acute - mortality | Anthracyclines | Usage | Daunorubicin | Young adults | Health aspects | Bone marrow | Chemotherapy | Consolidation | Kinases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1235 - 1248
Journal Article
13.